Home > Boards > US Listed > Biotechs >

Pain Therapeutics Inc. (PTIE)

PTIE RSS Feed
Add PTIE Price Alert      Hide Sticky   Hide Intro
Moderator: Stacking goods
Search This Board: 
Last Post: 5/4/2019 4:47:11 PM - Followers: 57 - Board type: Free - Posts Today: 0



PTIE new presentation out!

http://investor.paintrials.com/static-files/2830ee11-15b5-4ccc-ba99-d5dda492560b


PTIE's strong opioid drugs


REMOXY ER (extended-release oxycodone capsules CII) – REMOXY, our lead drug candidate, is a proprietary abuse-deterrent, twice-daily, oral oxycodone to treat severe chronic pain. T he REMOXY NDA was submitted to the FDA, with priority (six-month) review, in the first quarter of 2018 and was assigned a Prescription Drug User Fee Act ( “ PDUFA ” ) date of August 7, 2018 . The REMOXY NDA is requesting label claims against the injection, inhalation and nasal routes of abuse. The FDA held an Advisory Committee meeting (“Meeting”) on June 26, 2018 , to discuss the REMOXY NDA . At the conclusion of th e Meeting, members of the Advisory Committee voted 14 - to - 3 against regulatory approval of REMOXY ER. In addition, during the Meeting, the FDA expressed an opinion that current data for REMOXY ER may not support label claims against the injection and inhalation routes of abuse. At its sole discretion, the FDA may or may not follow the Advisory Committee’s recommendation. We own exclusive rights to develop and commercialize REMOXY worldwide, with a sales royalty obligation to one of our technology partners.

FENROCK ™ (transdermal fentanyl patch CII) – FENROCK is a proprietary, abuse-deterrent fentanyl skin patch to treat severe pain. This is an early-stage program that is substantially funded by a competitive research grant award from the NIDA, the primary agency of the U.S. government for research on drug abuse. We own exclusive, worldwide rights to FENROCK, with no royalty obligations to any third party.

PTI-125 – PTI-125 is a proprietary small molecule drug for the treatment of AD. In 201 8 , we completed a first-in-human Phase I study with PTI-125. This is an early-stage program that is substantially funded by competitive research grant awards from the NIH, the primary agency of the U.S. government for biomedical research. We own exclusive, worldwide rights to PTI-125, with no royalty obligations to any third party.

PTI-125DX – PTI-125 is a proprietary, blood-based diagnostic/biomarker to detect AD. This is an early -stage program that is substantially funded by competitive research grant awards from the NIH. We own exclusive, worldwide rights to PTI-125DX, with no royalty obligations to any third party.
 



http://www.paintrials.com/

http://finance.yahoo.com/q/h?s=PTIE


Pain Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of drugs for use in pain management, primarily in the area of opioid painkillers in the United States. Its Phase III clinical trial products include Remoxy, which is an anti-abuse version of long-acting oxycodone; and Oxytrex, which is an opioid painkiller for the treatment of chronic pain. The company has a strategic alliance with King Pharmaceuticals, Inc. for the development and commercialization of Remoxy and other abuse-resistant opioid painkillers. Pain Therapeutics was founded in 1998 and is based in South San Francisco, California.

PTIE
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PTIE News: Proxy Statement (definitive) (def 14a) 03/29/2019 08:25:06 AM
PTIE News: Annual Report (10-k) 03/29/2019 06:09:34 AM
PTIE News: Current Report Filing (8-k) 03/27/2019 03:04:18 PM
PTIE News: Pain Therapeutics Announces Name Change to Cassava Sciences, Inc. 03/27/2019 08:30:00 AM
PTIE News: Current Report Filing (8-k) 03/25/2019 01:10:38 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#1090   Where is new Message board to SAVA? Esa 05/04/19 04:47:11 PM
#1089   Sava Stacking goods 03/28/19 07:06:35 AM
#1088   https://findanews.com/2019/03/27/why-pain-therapeutics-inc-ptie-stock-was-rallyi Dogleg9 03/27/19 07:19:38 PM
#1087   News: $PTIE Pain Therapeutics Announces Name Change to whytestocks 03/27/19 02:40:42 PM
#1086   I was bidding back on .70 lol I Stacking goods 03/27/19 02:25:22 PM
#1085   Does,anyone recall why this fell back in June? Ty Vintage1776 03/13/19 04:54:29 PM
#1084   Jajaja ill need a moving truck on my Stacking goods 03/13/19 07:50:03 AM
#1083   lets see that $10+ pps again $$$$$ kingsransome 03/13/19 07:49:20 AM
#1082   This thing will blow up accumulations on these Stacking goods 03/13/19 06:27:29 AM
#1081   Steady accumulation invested_trader 03/12/19 09:39:25 PM
#1080   Aloha crickets board will be full soon Stacking goods 03/12/19 06:16:03 PM
#1079   Pain Therapeutics Charges FDA With Lack of Transparency, Stacking goods 03/05/19 08:39:57 AM
#1078   Nice action today here Stacking goods 03/05/19 08:39:21 AM
#1077   I think we have higher lows Stacking goods 02/25/19 05:23:38 PM
#1076   Finally some movement.. nice chart accumulation invested_trader 02/25/19 03:00:36 PM
#1075   shorts got out cheap so far,,we see whats kingsransome 02/05/19 11:39:54 AM
#1074   Well that didn't work out too well. jaytea 02/05/19 10:05:01 AM
#1073   Ash, how did you find out and where Codycrusher 02/05/19 02:54:22 AM
#1072   Maybe theyre finalizing a contract with a big otterman 02/04/19 03:36:32 PM
#1071   This is sort of bullcrap, no news coverage Codycrusher 02/04/19 11:54:35 AM
#1070   Ive never seen one where there hasnt been otterman 02/02/19 11:00:15 AM
#1069   Acelrx had their opioid related product approved in Lenard 02/02/19 09:30:14 AM
#1068   Actually thinking about it, I am betting they Codycrusher 02/02/19 07:37:01 AM
#1067   I’m still waiting on the official news release Codycrusher 02/01/19 11:46:26 PM
#1066   So what happened here? Surely news would at otterman 02/01/19 11:43:06 AM
#1065   Past 10Q + NIH Funding them from time ash111 02/01/19 04:01:48 AM
#1064   Define decent size company? Lenard 01/31/19 09:28:43 PM
#1063   How do you know how much cash they Codycrusher 01/31/19 05:43:27 PM
#1062   Agree. Company also has about $22m cash and ash111 01/31/19 07:30:20 AM
#1061   I think we can agree this is a Codycrusher 01/31/19 12:53:22 AM
#1060   Agreed on it they do get approved they’ll Codycrusher 01/31/19 12:46:22 AM
#1059   $1.35 in After Hours Trading. I thought this phil713 01/30/19 08:26:47 PM
#1058   Let’s pray for the best on this fda Codycrusher 01/30/19 07:59:59 PM
#1057   But then theres all that banning of opioids otterman 01/30/19 04:08:44 PM
#1056   Tomorrow is the day when PTIE meets with phil713 01/30/19 03:23:55 PM
#1055   gettin some juju here $PTIE jaytea 01/28/19 10:35:28 AM
#1054   “For years, opioid drugs were heavily marketed, inappropriately phil713 01/26/19 01:40:01 PM
#1053   acrx is down almost 50% since it was Lenard 01/24/19 07:28:45 AM
#1052   With this new opioid bill that Donald trump Codycrusher 01/24/19 01:03:32 AM
#1051   we got the pop and drop and sideways Lenard 01/16/19 02:21:44 PM
#1050   their several gaps all up to $25 $$$$$ kingsransome 01/16/19 09:25:44 AM
#1049   Great news can we go fill the gap Stacking goods 01/16/19 09:13:20 AM
#1048   NEWS OUT $$$$$ kingsransome 01/16/19 09:11:35 AM
#1047   Our time it’s here Stacking goods 01/07/19 09:31:40 AM
#1046   60 minutes is airing opioid story on the Lenard 12/16/18 02:33:54 AM
#1045   all gaps fill ...long $PTIE Hole shot King 12/06/18 11:40:34 AM
#1044   long aristotelisonassis 12/06/18 11:04:49 AM
#1043   Going to be an interesting month. Tax write-off Luna Tic 11/30/18 04:29:15 PM
#1042   Let’s go already!!! invested_trader 11/30/18 02:51:50 PM
#1041   Volume coming in may make a run at invested_trader 11/23/18 10:47:59 AM
PostSubject